Both in Pharmaceuticals
Spruce Biosciences vs Foghorn Therapeutics
Over the past year SPRB returned −59.1% and FHTX returned −49.4%; their daily moves had a correlation of 0.20.
SPRB −59.1% FHTX −49.4%Growth of $1, one year, split-adjusted
| Metric | SPRB | FHTX |
|---|---|---|
| Price | $42.81 | $2.13 |
| Market cap | $123.0M | $126.5M |
| Today | −3.91% | 0.00% |
| 1 month | −5.7% | +6.5% |
| 6 months | −27.9% | −54.1% |
| Year to date | −50.9% | −60.6% |
| 1 year | −61.1% | −51.7% |
| Revenue growth (YoY) | — | +112.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −44.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.4× |
| Net cash | $89.2M | $167.6M |
| Dividend yield | — | — |
| Volatility (60d) | 64.5% | 99.1% |
| Short % of float | 22.4% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).